Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy

European Journal of Cardio-thoracic Surgery

Volumn 46, Issue 1, 2014, Pages 116-120

  Camous, Julien ^a   Decrombecque, Thibaut ^a   Louvain Quintard, Virginie ^a   Doubine, Sylvie ^a   Dartevelle, Philippe ^a   Stéphan, François ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Antiphospholipid syndrome; Mortality; Pulmonary endarterectomy; Stroke; Thrombocytopenia

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DELIRIUM; DISEASE SEVERITY; ENDARTERECTOMY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MORBIDITY; NEUROLOGICAL COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY ENDARTERECTOMY; PULMONARY HYPERTENSION; SURGICAL MORTALITY; SURGICAL RISK; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; PULMONARY ARTERY; STROKE; SURGERY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE-CONTROL STUDIES; DELIRIUM; ENDARTERECTOMY; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY ARTERY; STROKE; THROMBOCYTOPENIA;

EID: 84899809566     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt572     Document Type: Article

References (25)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
2. Bonderman D, Wilkens H, Wakounig S, Schäfers H-J, Jansa P, Lindner J et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33:325-31.
3. Dartevelle P, Fadel E, Mussot S, Chapelier A, Hervé P, de Perrot M et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23: 637-48.
4. Jenkins DP, Madami M, Mayer E, Kerr K, Klepetko W, Morsolini M et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 2013;41:735-42.
5. Gorki H, Malinovski V, Stanbridge RDL. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg 2008;33:168-81.
6. Hogan WJ, McBane RD, Santrach PJ, Plumhoff EA, Olivier WC, Schaff HV et al. Antiphospholipid syndrome and perioperative hemostatic management of cardio valvular surgery. Mayo Clin Proc 2000;75:971-6.
7. Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115:2153-8.
8. Dartevelle P, Fadel E, Chapelier A, Macchiarini P, Cerrina J, Parquin F et al. Angioscopic video-assisted pulmonary endarterectomy for post-embolic pulmonary hypertension. Eur J Cardiothorac Surg 1999;16:38-43.
9. Asherson RA, Cervera R, Piette J-C, Shoenfeld Y, Espinosa G, Petri MA et al. Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine 2001;80:355-77.
10. Thistlethwaite PA, Kaneko K, Madami MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 2008;14:274-82.
11. Erkan D, Leibowitz E, Berman J, LocksinMD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002;29:843-9.
12. Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest 2007;132:624-36.
13. Vuylsteke A, Sharples L, Charman G, Kneeshaw J, Tsui S, Dunning J et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 2011;378: 1379-87.
14. Brey RL. Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome. J Autoimmun 2000;15:133-8.
15. Cervera R, Piette J-C, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-27.
16. Janardhan V, Wolf PA, Kase CS, Massaro JM, D'Agostino RB, Franzblau C et al. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 2004; 35:736-41.
17. Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ et al. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective study. Stroke 1997;28: 1660-5.
18. D'Armini AM, Totaro P, Nicolardi S, Morsolini M, Silvaggio G, Toscano F et al. Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy. Interact CardioVasc Thorac Surg 2010;10:418-22.
19. Levine JS, Branch WD, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
20. Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gomez-Puerta JA, Ramos-Casals M et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006;54:2568-76.
21. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa M-C, Piette J-C et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12: 530-4.
22. Trehel-Tursis V, Louvain-Quintard V, Zarrouki Y, Imbert A, Doubine S, Stéphan F. Clinical and biological features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU. Chest 2012;142:837-44.
23. Hoppensteadt DA, Walenga JM. The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia. Hematol Oncol Clin N Am 2008;22:1-18.
24. Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost 2009;7:1070-4.
25. Abu-Shakra M, Gladman DD, Urowitz MB, Frewell V. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am J Med 1995;99:624-8.